SD Biosensor Inc
KRX:137310
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SD Biosensor Inc
Accounts Payable
SD Biosensor Inc
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SD Biosensor Inc
KRX:137310
|
Accounts Payable
₩49.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Accounts Payable
₩40.2B
|
CAGR 3-Years
31%
|
CAGR 5-Years
34%
|
CAGR 10-Years
12%
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Accounts Payable
₩1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Accounts Payable
₩5.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Accounts Payable
₩7.1B
|
CAGR 3-Years
119%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Accounts Payable
₩3.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
20%
|
CAGR 10-Years
13%
|
|
SD Biosensor Inc
Glance View
SD Biosensor, Inc. develops and manufactures cholesterol, blood glucose testing and monitoring equipment. The company is headquartered in Suwon, Gyeonggi-Do. The company went IPO on 2021-07-16. The firm is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The firm is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is SD Biosensor Inc's Accounts Payable?
Accounts Payable
49.3B
KRW
Based on the financial report for Dec 31, 2024, SD Biosensor Inc's Accounts Payable amounts to 49.3B KRW.
What is SD Biosensor Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
33%
Over the last year, the Accounts Payable growth was 55%. The average annual Accounts Payable growth rates for SD Biosensor Inc have been -28% over the past three years , 33% over the past five years .
